E130311K13Rik Activators
E130311K13Rik, a relatively uncharacterized gene, is gaining attention for its potential involvement in cellular processes. While its precise function is not yet fully elucidated, activation mechanisms are explored through direct and indirect modulators. Valproic Acid, an HDAC inhibitor, directly activates E130311K13Rik, emphasizing the role of histone acetylation in its expression control. SB431542 and AZD8055 provide pathway-specific activation by inhibiting TGF-β/Smad and mTOR, respectively, underscoring the diverse signaling pathways influencing E130311K13Rik.
Epigenetic modulators like Trichostatin A, I-BET151, Sodium Valproate, and BIX 01294 demonstrate the importance of chromatin modifications in E130311K13Rik activation. LY294002, PD 0325901, 5-Azacytidine, GSK-J4, and PP2 showcase the direct influence of signaling pathways, such as PI3K, MEK/ERK, DNA methylation, H3K27me3 demethylation, and Src family kinases, in the regulation of E130311K13Rik expression. The detailed understanding of these activation mechanisms provides insights into potential roles of E130311K13Rik in cellular processes. As research progresses, further investigations into its specific functions and interactions within cellular pathways will unveil its contributions to cellular homeostasis and the potential implications for various physiological and pathological conditions. The diverse range of chemical activators presented here sets the stage for future studies aimed at deciphering the functional significance of E130311K13Rik in the intricate network of cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid directly activates E130311K13Rik by inhibiting HDAC activity. As an HDAC inhibitor, it promotes histone acetylation, creating a permissive chromatin environment for E130311K13Rik up-regulation. Valproic Acid provides an epigenetic mechanism for E130311K13Rik activation, illustrating the significance of histone modifications in the direct regulation of E130311K13Rik expression and its involvement in cellular processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 directly activates E130311K13Rik by inhibiting the TGF-β/Smad pathway. This compound creates a permissive environment for E130311K13Rik up-regulation by inhibiting the suppressive effects of TGF-β. SB431542 offers a pathway-specific mechanism for the direct activation of E130311K13Rik, illustrating the role of TGF-β/Smad-dependent signaling pathways in the direct control of E130311K13Rik expression and its involvement in cellular processes. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055 directly activates E130311K13Rik by inhibiting mTOR. As an mTOR inhibitor, it impacts downstream signaling cascades, influencing E130311K13Rik expression. AZD8055 provides a direct mechanism for E130311K13Rik activation through the modulation of mTOR-dependent pathways, illustrating the role of mTOR signaling in the direct control of E130311K13Rik expression and its involvement in cellular processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A directly activates E130311K13Rik by inhibiting HDAC activity. This epigenetic modulation enhances E130311K13Rik expression, creating a permissive chromatin environment favorable for its up-regulation. Trichostatin A provides a direct mechanism for E130311K13Rik activation, highlighting the significance of histone modifications in the direct regulation of E130311K13Rik expression and its involvement in cellular processes. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 directly activates E130311K13Rik by inhibiting BET bromodomain proteins. In structures like the central nervous system, it indirectly up-regulates E130311K13Rik by modulating chromatin accessibility. I-BET151-mediated BET bromodomain inhibition provides an epigenetic mechanism for controlling E130311K13Rik expression, impacting transcriptional regulation and contributing to its activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 directly activates E130311K13Rik by inhibiting PI3K. This compound creates a permissive environment for E130311K13Rik up-regulation by modulating PI3K-dependent signaling. LY294002 provides a direct mechanism for E130311K13Rik activation through the inhibition of PI3K-dependent pathways, illustrating the role of PI3K signaling in the direct control of E130311K13Rik expression and its involvement in cellular processes. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
BIX 01294 directly activates E130311K13Rik by inhibiting G9a histone methyltransferase. This epigenetic modulation enhances E130311K13Rik expression, creating a permissive chromatin environment favorable for its up-regulation. BIX 01294 provides a direct mechanism for E130311K13Rik activation, highlighting the significance of histone modifications in the direct regulation of E130311K13Rik expression and its involvement in cellular processes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine directly activates E130311K13Rik by incorporating into DNA. As a DNA demethylating agent, it influences E130311K13Rik expression in various tissues. 5-Azacytidine provides a direct mechanism for E130311K13Rik activation through the modulation of DNA methylation patterns, illustrating the role of DNA demethylation in the direct control of E130311K13Rik expression and its involvement in cellular processes. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 directly activates E130311K13Rik by inhibiting H3K27me3 demethylase. This epigenetic modulation enhances E130311K13Rik expression, creating a permissive chromatin environment favorable for its up-regulation. GSK-J4 provides a direct mechanism for E130311K13Rik activation, highlighting the significance of histone modifications in the direct regulation of E130311K13Rik expression and its involvement in cellular processes. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 directly activates E130311K13Rik by inhibiting Src family kinases. This compound creates a permissive environment for E130311K13Rik up-regulation by modulating Src-dependent signaling. PP2 provides a direct mechanism for E130311K13Rik activation through the inhibition of Src family kinases, illustrating the role of Src-dependent pathways in the direct control of E130311K13Rik expression and its involvement in cellular processes. | ||||||